• SENSEX
    NIFTY 50
Healthcare

Antibody drug lowers risk of death in elderly COVID-19 patients: Cuban study

Updated : July 31, 2020 08:21 AM IST

The patients received either one or two intravenous doses of itolizumab along with the standard treatments used in Cuba at the time.
Only two patients required oxygen therapy after the first dose, and all but one were discharged from the hospital in 14 days.
Antibody drug lowers risk of death in elderly COVID-19 patients: Cuban study

You May Also Like

Live TV
Advertisement